83 related articles for article (PubMed ID: 12365600)
1. Effect of microcrystalline chitosan on the solubility of ibuprofen.
Bodek KH
Acta Pol Pharm; 2002; 59(2):105-8. PubMed ID: 12365600
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of microcrystalline chitosan properties as a drug carrier. Part II. The influence of microcrystalline chitosan on release rate of ketoprofen.
Bodek KH
Acta Pol Pharm; 2001; 58(3):185-94. PubMed ID: 11712735
[TBL] [Abstract][Full Text] [Related]
3. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers.
Williams AC; Timmins P; Lu M; Forbes RT
Eur J Pharm Sci; 2005 Nov; 26(3-4):288-94. PubMed ID: 16087323
[TBL] [Abstract][Full Text] [Related]
4. Melt sonocrystallization of ibuprofen: effect on crystal properties.
Manish M; Harshal J; Anant P
Eur J Pharm Sci; 2005 May; 25(1):41-8. PubMed ID: 15854799
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of properties microcrystalline chitosan as a drug carrier. Part 1. In vitro release of diclofenac from mictocrystalline chitosan hydrogel.
Bodek KH
Acta Pol Pharm; 2000; 57(6):431-40. PubMed ID: 11243249
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation.
Dhawan S; Singla AK
Biotech Histochem; 2003 Oct; 78(5):243-54. PubMed ID: 14989642
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules.
Säkkinen M; Seppälä U; Heinänen P; Marvola M
Eur J Pharm Biopharm; 2002 Jul; 54(1):33-40. PubMed ID: 12084500
[TBL] [Abstract][Full Text] [Related]
8. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
9. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
[TBL] [Abstract][Full Text] [Related]
10. Polymer-mediated disruption of drug crystallinity.
Rawlinson CF; Williams AC; Timmins P; Grimsey I
Int J Pharm; 2007 May; 336(1):42-8. PubMed ID: 17157459
[TBL] [Abstract][Full Text] [Related]
11. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
Chatchawalsaisin J; Podczeck F; Newton JM
Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
13. Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug.
Aiedeh KM; Khatib HA; Taha MO; Al-Zoubi N
Pharmazie; 2006 Apr; 61(4):306-11. PubMed ID: 16649543
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel-forming excipient.
Säkkinen M; Linna A; Ojala S; Jürjenson H; Veski P; Marvola M
Int J Pharm; 2003 Jan; 250(1):227-37. PubMed ID: 12480288
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal powered time model for release kinetic analysis of ibuprofen solid dispersions in oleaster powder, microcrystalline cellulose and crospovidone.
Mohammadi G; Barzegar-Jalali M; Valizadeh H; Nazemiyeh H; Barzegar-Jalali A; Siahi Shadbad MR; Adibkia K; Zare M
J Pharm Pharm Sci; 2010; 13(2):152-61. PubMed ID: 20816002
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
[TBL] [Abstract][Full Text] [Related]
17. Chitosan microspheres as a potential carrier for drugs.
Sinha VR; Singla AK; Wadhawan S; Kaushik R; Kumria R; Bansal K; Dhawan S
Int J Pharm; 2004 Apr; 274(1-2):1-33. PubMed ID: 15072779
[TBL] [Abstract][Full Text] [Related]
18. Initial salt screening procedures for manufacturing ibuprofen.
Lee T; Wang YW
Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
[TBL] [Abstract][Full Text] [Related]
19. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
20. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
